SEC Form 4 research
| Issuer | Arcutis Biotherapeutics, Inc. |
|---|---|
| Tickers | ARQT |
| Reporting owners | 40 |
| Officers and directors | 20 |
| Last public filing | 2026-09-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-16 | Matsuda Masaru | S | 3,674 | $25 | Not reported |
| 2026-09-17 | 2026-09-15 | Welgus Howard G. | S | 4,730 | $24.18 | Not reported |
| 2026-09-10 | 2026-09-08 | Matsuda Masaru | S | 9,989 | $25.03 | Not reported |
| 2026-08-28 | 2026-08-27 | Curran Terrie | S | 27,052 | $25.03 | Not reported |
| 2026-08-28 | 2026-08-27 | Curran Terrie | S | 11,148 | $25.03 | Not reported |
| 2026-08-24 | 2026-08-20 | Curran Terrie | S | 1,072 | $26.04 | Not reported |
| 2026-08-21 | 2026-08-19 | Burnett Patrick | S | 1,697 | $27 | Not reported |
| 2026-08-19 | 2026-08-17 | Welgus Howard G. | S | 4,730 | $26.18 | Not reported |
| 2026-08-13 | 2026-08-12 | Burnett Patrick | S | 6,700 | $26.08 | Not reported |
| 2026-08-13 | 2026-08-11 | Burnett Patrick | S | 8,300 | $26.52 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.